PMS-001

N/A

Report date: 2025/05/15 20:00:08
NME

Base Information

Drug NamePMS-001
Drug Alias NamePMS-001
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlutamate receptor ionotropic AMPA modulators
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsIschemic StrokeDepressive Disorder, MajorSubstance-Related Disorders +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesQingdao Pumeisheng Medical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesQingdao Pumeisheng Medical Technology Co Ltd +[2] 
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorSubstance-Related DisordersAlzheimer Disease +[4] 
Inactive IndicationsIschemic StrokeStroke

Other Information

ATC CodeN/A
Related LinksN/A